Del. Justices Probe Unclear Terms In AstraZeneca Merger Pact
Investors in a company developing a cutting-edge cancer therapy that AstraZeneca PLC bought in 2013 but never brought to market struggled to convince Delaware's Supreme Court on Wednesday that they deserved...To view the full article, register now.
Already a subscriber? Click here to view full article